Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
Varettoni M, Boveri E, Zibellini S, Tedeschi A, Candido C, Ferretti VV, Rizzo E, Doni E, Merli M, Farina L, Goldaniga M, Gallì A, Rattotti S, Frustaci AM, Deodato M, Bandiera L, Isimbaldi G, Uccella S, Cabras AD, Gianelli U, Baldini L, Paulli M, Arcaini L. Varettoni M, et al. Among authors: baldini l. Am J Hematol. 2019 Nov;94(11):1193-1199. doi: 10.1002/ajh.25600. Epub 2019 Sep 9. Am J Hematol. 2019. PMID: 31378966 Free article.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S, Ferretti VV, Rusconi C, Rossi A, Fogazzi S, Baldini L, Pioltelli P, Balzarotti M, Farina L, Ferreri AJM, Laszlo D, Speziale V, Varettoni M, Sciarra R, Morello L, Tedeschi A, Frigeni M, Defrancesco I, Zerbi C, Flospergher E, Nizzoli ME, Morra E, Arcaini L; “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup). Rattotti S, et al. Among authors: baldini l. Hematol Oncol. 2019 Apr;37(2):160-167. doi: 10.1002/hon.2575. Epub 2019 Feb 22. Hematol Oncol. 2019. PMID: 30726562 Clinical Trial.
Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.
Tedeschi A, Ricci F, Goldaniga MC, Benevolo G, Varettoni M, Motta M, Pioltelli P, Gini G, Barate' C, Luraschi A, Vismara E, Frustaci AM, Nichelatti M, Vitolo U, Baldini L, Morra E. Tedeschi A, et al. Among authors: baldini l. Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):231-4. doi: 10.1016/j.clml.2013.02.011. Epub 2013 Mar 13. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23490992
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.
Luminari S, Goldaniga M, Cesaretti M, Orsucci L, Tucci A, Pulsoni A, Salvi F, Arcaini L, Carella AM, Tedeschi A, Pinto A, Stelitano C, Baldini L. Luminari S, et al. Among authors: baldini l. Leuk Lymphoma. 2016;57(4):880-7. doi: 10.3109/10428194.2015.1091934. Epub 2016 Feb 8. Leuk Lymphoma. 2016. PMID: 26379040 Clinical Trial.
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia.
Merlini G, Baldini L, Broglia C, Comelli M, Goldaniga M, Palladini G, Deliliers GL, Gobbi PG. Merlini G, et al. Among authors: baldini l. Semin Oncol. 2003 Apr;30(2):211-5. doi: 10.1053/sonc.2003.50064. Semin Oncol. 2003. PMID: 12720138
B-cell nasal lymphoma mimicking hyperplastic chronic rhinitis.
Cantarella G, Peri A, Goldaniga MC, Gianelli U, Baldini L. Cantarella G, et al. Among authors: baldini l. Otolaryngol Head Neck Surg. 2006 Jul;135(1):165-7. doi: 10.1016/j.otohns.2005.03.042. Otolaryngol Head Neck Surg. 2006. PMID: 16815207 No abstract available.
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
Goldaniga M, Ferrario A, Cortelazzo S, Guffanti A, Pavone E, Ambrosetti A, Marcheselli L, Rossi F, Luminari S, Rossi A, Cro L, Federico M, Lambertenghi Deliliers G, Baldini L. Goldaniga M, et al. Among authors: baldini l. Am J Hematol. 2008 May;83(5):349-54. doi: 10.1002/ajh.21065. Am J Hematol. 2008. PMID: 18186522 Free article.
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Ferrario A, Merli F, Luminari S, Stelitano C, Mannina D, Russo M, Mazza P, Marcheselli L, Goldaniga MC, Federico M, Baldini L; Gruppo Italiano per lo Studio dei Linfomi. Ferrario A, et al. Among authors: baldini l. Ann Hematol. 2011 Mar;90(3):323-30. doi: 10.1007/s00277-010-1067-1. Epub 2010 Sep 17. Ann Hematol. 2011. PMID: 20848104 Clinical Trial.
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
Iurlo A, Palandri F, Maria Elli E, Cattaneo D, Bucelli C, Sciumè M, Vincelli D, Brioschi F, Auteri G, Croci GA, Guerneri S, Isimbaldi G, Sabattini E, Cortinovis I, Bossi A, Rosti V, Martino B, Baldini L, Gianelli U. Iurlo A, et al. Among authors: baldini l. Hematol Oncol. 2021 Feb;39(1):123-128. doi: 10.1002/hon.2808. Epub 2020 Oct 4. Hematol Oncol. 2021. PMID: 32979286
524 results